The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Open accessAbstract
Background: Colorectal adenocarcinoma (CRC) is the third leading cause of death in the United States. One of the histologic subtypes of CRC is signet-ring cell carcinoma (SRCC), which has a distinct molecular and tumor biology from that of adenocarcinoma. Primary SRCC diagnosed at an early stage is very rare as most cases are detected at an advanced stage. Therefore, overall prognosis of SRCC is poor. Case Presentation: A 36-year-old female presented to her primary care physician with new-onset progressive right lower quadrant pain without any significant past medical or family history. Computed tomography scan of the abdomen and pelvis with contrast showed a 4.9 × 3.5 × 3.1 cm, lobulated, septated cystic mass arising from the cecum. The mass demonstrated wall enhancement and contained focal areas of coarse calcification. There was nodal involvement either locally or distally. The patient underwent right hemicolectomy, and pathology revealed a high-grade mucinous carcinoma with signet-ring cell variant invading through the muscularis propria and into the subserosal adipose tissue. The margins were negative for tumor, and no lymphovascular or perineural invasion was noted. None of the 14 resected pericolonic lymph nodes was positive for malignancy. Hence, she was staged as pT3, pN0, pMx-stage IIA. The appendix was not involved. Microsatellite instability testing showed the preservation of MLH1, PMS2, MSH2 and MSH6 proteins by IHC and PCR. Carcinoembryonic antigen level was within normal limits. Due to the patient's young age, aggressive histology and microsatellite-stable status, adjuvant fluropyrimidine (5-FU)-based therapy with the single agent capecitabine was initiated. The patient completed 6 months of adjuvant therapy and has been disease free for approximately 18 months. Conclusion: Primary SRCC of the cecum is a rare disease. Given the poor prognosis of these patients, early-stage disease with microsatellite-stable patients should be considered for adjuvant 5-FU-based therapy in an attempt to prevent recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Carcinoma of the Colon and Rectum
Welch, C. E., & Burke, J. F. (1962) · New England Journal of Medicine · doi:10.1056/nejm196202012660501 · Cited by 565
Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis
Verhulst, J., Ferdinande, L., Demetter, P., & Ceelen, W. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200340 · Cited by 260
Ogino, S., Brahmandam, M., Cantor, M., Namgyal, C., Kawasaki, T., Kirkner, G., Meyerhardt, J. A., Loda, M., & Fuchs, C. S. (2006) · Modern Pathology · doi:10.1038/modpathol.3800482 · Cited by 252
Primary Mucinous Adenocarcinomas and Signet-Ring Cell Carcinomas of Colon and Rectum
Secco, G. B., Fardelli, R., Campora, E., Lapertosa, G., Gentile, R., Zoli, S., & Prior, C. (2009) · Oncology · doi:10.1159/000227306 · Cited by 149
Signet-ring cell carcinoma of colorectum—current perspectives and molecular biology
Gopalan, V., Smith, R. A., Ho, Y., & Lam, A. K.-Y. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-1037-z · Cited by 92
Sargent, D. J., Shi, Q., Yothers, G., Tejpar, S., Bertagnolli, M. M., Thibodeau, S. N., André, T., Labianca, R., Gallinger, S., Hamilton, S. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.3507 · Cited by 80
Research works printed but not linked: 8
- 10.1097/SLA.0b013e3182a69f7e · doi:10.1097/sla.0b013e3182a69f7e
- 10.1016/S1470-2045(11)70058-4 · DOI
- 10.1002/ijc.28981 · doi:10.1002/ijc.28981
- 10.1007/s10350-004-0932-1 · doi:10.1007/s10350-004-0932-1
- 10.5009/gnl.2012.6.1.129 · doi:10.5009/gnl.2012.6.1.129
- 10.1038/modpathol.2008.170 · doi:10.1038/modpathol.2008.170
- 10.3748/wjg.14.2118 · doi:10.3748/wjg.14.2118
- 10.1111/j.1349-7006.2003.tb01462.x · DOI
Cited by
Items 101–145 of 145
Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes
Kandimalla, R., Aqil, F., Alhakeem, S., Jeyabalan, J., Tyagi, N., Agrawal, A., Yan, J., Spencer, W., Bondada, S., & Gupta, R. (2021) · Cancers · doi:10.3390/cancers13153700 · Cited by 99
miR‐144‐5p enhances the Radiosensitivity of non‐small‐cell lung Cancer cells via targeting ATF2
Song, L., Peng, L., Hua, S., Li, X., Ma, L., Jie, J., Chen, D., Wang, Y., & Li, D. (2018) · BioMed Research International · doi:10.1155/2018/5109497 · Cited by 93
Clinical use of proteasome inhibitors in the treatment of multiple myeloma
Merin, N., & Kelly, K. (2014) · Pharmaceuticals · doi:10.3390/ph8010001 · Cited by 90
Hurtado-de-Mendoza, A., Cabling, M. L., Lobo, T., Dash, C., & Sheppard, V. B. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.03.006 · Cited by 79
Shi, L., Wu, Z., Miao, J., Du, S., Ai, S., Xu, E., Feng, M., Song, J., & Guan, W. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-03-0136 · Cited by 79
Yu, Y., Lin, Y., Xu, C., Lin, K., Ye, Q., Wang, X., Xie, S., Chen, R., & Lin, J. (2018) · Biomedical Optics Express · doi:10.1364/boe.9.006053 · Cited by 79
Yu, T., Guo, Z., Fan, H., Song, J., Liu, Y., Gao, Z., & Wang, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.8232 · Cited by 70
Wang, B., Zhang, W., Zhang, G., Kwong, L., Lu, H., Tan, J., Sadek, N., Xiao, M., Zhang, J., Labrie, M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01911-5 · Cited by 66
Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
Han, Shin, D. H., Kim, J. S., Weon, K. Y., Jang, C.-Y., & Kim, J.-S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s95850 · Cited by 65
Serrano, J., Andersen, D. K., Forsmark, C. E., Pandol, S. J., Feng, Z., Srivastava, S., & Rinaudo, J. A. S. (2018) · Pancreas · doi:10.1097/mpa.0000000000001167 · Cited by 57
The role of endoscopic ultrasound in pancreatic cancer screening
Bhutani, M., Koduru, P., Joshi, V., Saxena, P., Suzuki, R., Irisawa, A., & Yamao, K. (2016) · Endoscopic Ultrasound · doi:10.4103/2303-9027.175876 · Cited by 55
Han, B., Qu, C., Park, K., Konieczny, S. F., & Korc, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.003 · Cited by 53
Xu, J., Xiong, G., Cao, Z., Huang, H., Wang, T., You, L., Zhou, L., Zheng, L., Hu, Y., Zhang, T., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0406-z · Cited by 53
Yun, Y. H., Kim, Y. A., Lee, M. K., Sim, J. A., Nam, B.-H., Kim, S., Lee, E. S., Noh, D.-Y., Lim, J.-Y., Kim, S., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3290-9 · Cited by 47
Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer
Elayapillai, S., Ramraj, S., Benbrook, D. M., Bieniasz, M., Wang, L., Pathuri, G., Isingizwe, Z. R., Kennedy, A. L., Zhao, Y. D., Lightfoot, S., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.10.010 · Cited by 50
Dong, R., Qiang, W., Guo, H., Xu, X., Kim, J. J., Mazar, A., Kong, B., & Wei, J.-J. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0318-6 · Cited by 49
Xie, C., Jin, J., Bao, X., Zhan, W.-H., Han, T.-Y., Gan, M., Zhang, C., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.6311 · Cited by 47
Wu, W., Zhang, C., Lin, W., Chen, Q., Guo, X., Qian, Y., & Zhang, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119575 · Cited by 47
Assessment of burden and coping strategies among caregivers of cancer patients in sub-Saharan Africa
Akpan-Idiok, P. A., Ehiemere, I. O., Asuquo, E. F., Chabo, J. A. U., & Osuchukwu, E. C. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i12.1045 · Cited by 44
A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection
Dumstrei, K., Chen, H., & Brenner, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7098 · Cited by 43
Liu, L., Liu, W., Wang, L., Zhu, T., Zhong, J., & Xie, N. (2017) · Oncology Letters · doi:10.3892/ol.2017.7223 · Cited by 42
Mehta, A. R., & Armstrong, A. J. (2016) · Therapeutic Advances in Urology · doi:10.1177/1756287215603558 · Cited by 41
Penile rehabilitation after radical prostatectomy: does it work?
(2015) · PubMed Central · doi:10.3978/j.issn.2223-4683.2015.02.01 · Cited by 40
Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma
Desai, V., Patel, K., Sheth, R., Barlass, U., Chan, Y.-M., Sclamberg, J., & Bishehsari, F. (2020) · Visceral Medicine · doi:10.1159/000507457 · Cited by 40
Salemi, M., Mogavero, M. P., Lanza, G., Mongioì, L. M., Calogero, A. E., & Ferri, R. (2022) · Cells · doi:10.3390/cells11121930 · Cited by 39
Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts
Zhu, Cheng, M., Yang, Z., Zeng, C., Chen, J., Xie, Y., Luo, S., Zhang, K., Zhou, S.-F., & Lv, N. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s71466 · Cited by 38
García-Fernández, M., Karras, P., Checinska, A., Cañón, E., Calvo, G. T., Gómez-López, G., Cifdaloz, M., Colmenar, A., Espinosa-Hevia, L., Olmeda, D., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1199301 · Cited by 35
Shah, J. J., Feng, L., Thomas, S. K., Berkova, Z., Weber, D. M., Wang, M., Qazilbash, M. H., Champlin, R. E., Mendoza, T. R., Cleeland, C., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.4 · Cited by 35
Carrillo, A. M., Hicks, M., Khabele, D., & Eischen, C. M. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0089 · Cited by 31
Lin, M., Chen, Y., Lee, M., Weng, K., Chang, H., Yu, S., Dong, B., Kuo, F., Hung, L., Liu, L., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8557 · Cited by 30
Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment
Kao, A. T., Cabanlong, C. V., Padilla, K., & Xue, X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.025 · Cited by 30
CK1α overexpression correlates with poor survival in colorectal cancer
Richter, J., Kretz, A.-L., Lemke, J., Fauler, M., Werner, J.-U., Paschke, S., Leithäuser, F., Henne-Bruns, D., Hillenbrand, A., & Knippschild, U. (2018) · BMC Cancer · doi:10.1186/s12885-018-4019-0 · Cited by 28
Augustine, T. A., Baig, M., Sood, A., Budagov, T., Atzmon, G., Mariadason, J. M., Aparo, S., Maitra, R., & Goel, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.561 · Cited by 27
Su, L., & Liu, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8669 · Cited by 27
Sun, J., Shen, D., Zheng, Y., Ren, H., Liu, H., Chen, X., & Gao, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s271496 · Cited by 24
Adenoma detection rate in 41,010 patients from Southwest China
CAI, B., LIU, Z., XU, Y., WEI, W., & ZHANG, S. (2015) · Oncology Letters · doi:10.3892/ol.2015.3005 · Cited by 22
hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma
Anwar, S. L., Krech, T., Hasemeier, B., Schipper, E., Schweitzer, N., Vogel, A., Kreipe, H., Buurman, R., Skawran, B., & Lehmann, U. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i9.1568 · Cited by 21
IL-23 Inhibits Melanoma Development by Augmenting DNA Repair and Modulating T Cell Subpopulations
Nasti, T. H., Cochran, J. B., Vachhani, R. V., McKay, K., Tsuruta, Y., Athar, M., Timares, L., & Elmets, C. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601455 · Cited by 19
Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer
Carriere, P., Kapur, N., Mir, H., Ward, A., & Singh, S. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4489 · Cited by 18
Jin, Y., Wang, H., Ma, X., Liang, X., Liu, X., & Wang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127229 · Cited by 17
The effects of bufadienolides on HER2 overexpressing breast cancer cells
Wang, T., Mu, L., Jin, H., Zhang, P., Wang, Y., Ma, X., Pan, J., Miao, J., & Yuan, Y. (2016) · Tumor Biology · doi:10.1007/s13277-015-4381-3 · Cited by 15
Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
Gerov, V., Gerova, D., Micheva, I., Nikolova, M., Mihaylova, G., & Galunska, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134440 · Cited by 13
Goo, A.-J., Song, Y.-M., Shin, J., & Ko, H. (2016) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2016.37.4.228 · Cited by 11
Cancerous inhibitor of protein phosphatase 2A regulates cisplatin resistance in ovarian cancer
Li, W., Zhang, H., Yang, L., & Wang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9653 · Cited by 9
Shen, C.-Y., Chen, L.-H., Lin, Y.-F., Lai, L.-C., Chuang, E. Y., & Tsai, M.-H. (2016) · Oncotarget · doi:10.18632/oncotarget.13237 · Cited by 8
Metadata
- Authors
- Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N.
- Venue
- Case Reports in Oncology
- Publisher
- S. Karger AG
- Published
- 2015-11-04
- Volume
- 8
- Issue
- 3
- Pages
- 466-471
- ISSN
- 1662-6575 (ISSN-L)
- OpenAlex
- W2219978888
- Cited by
- 5,273
- References
- 8
- FWCI
- 508.86
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.